Research ArticleExperimental Studies
Treatment of Breast Cancer Cells by IGF1R Tyrosine Kinase Inhibitor Combined with Conventional Systemic Drugs
H. HARTOG, W.T.A. VAN DER GRAAF, H.M. BOEZEN and J. WESSELING
Anticancer Research April 2012, 32 (4) 1309-1318;